Complications of the COX-2 Inhibitors Parecoxib and Valdecoxib after Cardiac Surgery
Top Cited Papers
- 17 March 2005
- journal article
- clinical trial
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 352 (11), 1081-1091
- https://doi.org/10.1056/nejmoa050330
Abstract
Valdecoxib and its intravenous prodrug parecoxib are used to treat postoperative pain but may involve risk after coronary-artery bypass grafting (CABG). We conducted a randomized trial to assess the safety of these drugs after CABG.Keywords
This publication has 30 references indexed in Scilit:
- Cardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention TrialNew England Journal of Medicine, 2005
- Cardiovascular Risk Associated with Celecoxib in a Clinical Trial for Colorectal Adenoma PreventionNew England Journal of Medicine, 2005
- Halt of Celebrex Study Threatens Drug's Future, Other TrialsScience, 2004
- Cyclooxygenase-2 Inhibitors in Postoperative Pain ManagementAnesthesiology, 2003
- Functional and Biochemical Evaluation of Platelet Aspirin Resistance After Coronary Artery Bypass SurgeryCirculation, 2003
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- A double-blind, randomized comparison of intramuscularly and intravenously administered parecoxib sodium versus ketorolac and placebo in a post—oral surgery pain modelClinical Therapeutics, 2001
- ACC/AHA guidelines for the management of patients with unstable angina and non–st-segment elevation myocardial infarctionJournal of the American College of Cardiology, 2000
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke, 1993
- Elevated plasma fibrinopeptide A and thromboxane B2 levels during cardiopulmonary bypass.Circulation, 1980